Literature DB >> 2190097

Fc receptor phosphorylation during receptor-mediated control of B-cell activation.

W Hunziker1, T Koch, J A Whitney, I Mellman.   

Abstract

It is well known that Fc receptors for IgG (FcRII) on macrophages mediate the endocytosis of antibody-antigen complexes and signal the release of inflammatory and cytotoxic agents. FcRII are also expressed at high levels on B cells where they are less involved in endocytosis than in modulating B-cell activation by membrane immunoglobulins. Although crosslinking of membrane immunoglobulins can result in B-cell differentiation and proliferation through stimulation of phospholipase C, mobilization of intracellular Ca2+, and activation of protein kinase C, crosslinking FcR with membrane immunoglobulins confers a dominant inhibitory signal that prevents or aborts activation. This form of regulation may have a role in the induction of tolerance by IgG and in controlling the B-cell repertoire by anti-idiotypes. The different functions of FcR on B cells and macrophages may reflect the fact that these cell types express closely related but distinct FcR isoforms. We have recently found that the main lymphocyte FcR isoform, FcRII-B1, is unable to mediate endocytosis by way of coated pits and coated vesicles owing to an in-frame insertion of 47 amino acids in its cytoplasmic tail. Here we show that this insert, absent from the FcRII-B2 macrophage isoform, also contains serine phosphorylation sites that may have a role in the ability of FcR to regulate B-cell activation through membrane immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190097     DOI: 10.1038/345628a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

Review 1.  Surface molecules involved in B lymphocyte function.

Authors:  P Möller; A Eichelmann; G Moldenhauer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  The biology and pathology of Fc receptors.

Authors:  M Sandor; R G Lynch
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

3.  Biochemical characterization of murine Fc gamma RI.

Authors:  A L Quilliam; N Osman; I F McKenzie; P M Hogarth
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

Review 4.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

Review 5.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

6.  Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors:  J H Noseworthy; P C O'Brien; B G van Engelen; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  Protein-tyrosine kinase activity tightly associated with human type II Fc gamma receptors.

Authors:  G Sármay; I Pecht; J Gergely
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.

Authors:  A G Hadley; B Zupanska; B M Kumpel; K A Leader
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 9.  Regulation of the expression of murine alpha- and beta-Fc gamma R genes.

Authors:  M Daëron
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

10.  Modulation of the Fc gamma RII and Fc gamma RIII induced by GM-CSF, IFN-gamma and IL-4 on murine eosinophils.

Authors:  B de Andrés; B Cárdaba; V del Pozo; E Martín-Orozco; S Gallardo; P Tramón; P Palomino; C Lahoz
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.